NUGC-3 Cells
759,00 CAD$*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
Renseignements généraux
| Description | NUGC-3 is a human gastric carcinoma cell line derived from the primary tumor of an patient with poorly differentiated adenocarcinoma. This cell line serves as an important model for studying gastric cancer, a malignancy characterized by high heterogeneity and poor prognosis in advanced stages. NUGC-3 cells are widely utilized in cancer biology research, particularly in the areas of tumor progression, metastasis, and the evaluation of novel therapeutic agents targeting gastric cancer. NUGC-3 cells exhibit epithelial morphology and are adherent under standard cell culture conditions. These cells carry genetic and molecular alterations associated with gastric adenocarcinoma, including mutations in key oncogenes and tumor suppressor genes. Researchers have leveraged this cell line to investigate signaling pathways critical to tumor growth, such as the dysregulation of EGFR, HER2, and other receptor tyrosine kinase pathways, as well as the epithelial-mesenchymal transition (EMT) process, which plays a role in cancer invasion and metastasis. This cell line is also suitable for studies on chemotherapeutic resistance, as gastric cancer frequently develops resistance to standard treatments. NUGC-3 cells are employed in drug screening assays to test the efficacy of cytotoxic agents, targeted therapies, and combination treatments. Additionally, they provide a robust platform for exploring tumor-stroma interactions and the role of the tumor microenvironment in gastric cancer progression. As such, NUGC-3 remains a valuable resource for advancing gastric cancer research and therapeutic development. |
|---|---|
| Organisme | Human |
| Tissu | Stomach |
| Maladie | Gastric adenocarcinoma |
| Site métastatique | Brachialis muscle |
| Synonymes | NUGC3, NU-GC-3, Nagoya University-Gastric Cancer-3 |
Caractéristiques
| Âge | 72 years |
|---|---|
| Genre | Male |
| Origine ethnique | Japanese |
| Morphologie | Fibroblast-like |
| Propriétés de croissance | Adherent |
Données réglementaires
| Référence | NUGC-3 (Cytion catalog number 305503) |
|---|---|
| Niveau de biosécurité | 1 |
| NCBI_Numéro d'identification fiscale | 9606 |
| Cellosaurus - Numéro d'enregistrement | CVCL_1612 |
Données biomoléculaires
| Profil mutationnel | Mutation: TP53; Simple; p.Tyr220Cys (c.659A>G), Unspecified |
|---|
Manipulation
| Milieu de culture | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Suppléments | Supplement the medium with 10% FBS |
| Réactif de dissociation | Trypsin(0.25%)-EDTA(0.02%) |
| Repiquage | For routine adherent cell culture: Aspirate the old culture medium from the adherent cells, and wash them with PBS to remove any remaining medium. After aspirating the PBS, add the appropriate volume of Trypsin/EDTA solution based on the culture vessel size (e.g., 1 ml for a T25 flask, 3 ml for a T75 flask) and incubate at room temperature or 37°C until the cells detach (5-10 minutes). Monitor detachment under a microscope, and gently tap the vessel if necessary to release the cells. Once detached, add complete medium to inactivate the Trypsin/EDTA, gently resuspend the cells, and transfer an aliquot of the cell suspension into a new culture vessel containing fresh medium. Place the vessel in an incubator set to 37°C with 5% CO2, and change the medium every 2-3 days. |
| Milieu de congélation | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Décongélation et culture des cellules |
|
| Atmosphère d'incubation | 37°C, 5% CO2, humidified atmosphere. |
| Conditions d'expédition | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Conditions d'entreposage | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Contrôle de la qualité et analyse moléculaire
| Stérilité | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|